SciELO - Scientific Electronic Library Online

 
vol.73 issue5Coediting the Revista de Investigación Clínica with Ruben Lisker, 1974-1987 author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de investigación clínica

On-line version ISSN 2564-8896Print version ISSN 0034-8376

Rev. invest. clín. vol.73 n.5 Ciudad de México Sep./Oct. 2021  Epub Oct 18, 2021

https://doi.org/10.24875/ric.21000363 

Letters to editor

If We Have Seen Further, It is By Standing on The Shoulders of Giants

Guillermo J. Ruiz-Argüelles1  * 

David Gómez-Almaguer2 

Guillermo J. Ruiz-Delgado1 

Andrés  Gómez-De-León2 

Iván Murrieta-Álvarez1 

1Centro de Hematología y Medicina Interna de Puebla, Clínica Ruiz, Puebla, Puebl., Mexico

2Hospital Universitario de Nuevo León, Monterrey, NL., Mexico


Isaac Newton, 1675

Dear Editor,

In April 1960, Dr. Álvaro Gómez-Leal, a hematologist trained at the Instituto Nacional de Nutrición Salvador Zubirán (INCMNSZ), presented during the first meeting of the Agrupación Mexicana para el Estudio de la Hematología, A.C., data on a transplant of allogeneic stem cells in a patient with acute leukemia done in Monterrey, Mexico (Fig. 1A): the patient received high-dose chemotherapy followed by stem cells from the bone marrow of his brother, improving and obtaining remission for months but relapsing and subsequently died. This was the first report of a hematopoietic stem cell transplantation (HSCT) conducted in Mexico, only 4 years after the pioneer work by E. Donnall Thomas in Cooperstown, New York, USA1. Years later, in 1980, Ricardo Sosa and his coworkers at the INCMNSZ conducted and published formally a HSCT2. Since then, more than 7500 HSCTs have been performed in México in over 10 HSCT centers, headed by physicians either trained at the INCMNSZ of by their trainees (Fig. 1B).

Figure 1 (A) Abstract of the paper presented by Dr. Alvaro Gomez-Leal in April 18, 1960, during the first congress of the Agrupación Mexicana para el Estudio de la Hematologia held in Mexico City. (B) Number of hematopoietic stem cell transplants conducted in some centers in México. IMSS: Instituto Mexicano del Seguro Social; UMAE: Unidad Médica de Alta Especialidad; UANL: Universidad Autónoma de Nuevo León; CMN: Centro Médico Nacional; ISSSTE: Instituto de Seguridad y Servicios Sociales para Trabajadores del Estado; INP: Instituto Nacional de Pediatría; INCMNSZ: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán; ABC: American British Cowdray. 

May this be an homage to the institution which now celebrates its 75th anniversary and to the physicians involved in starting the HSCT activity in Mexico, who taught us that the obstacles are there to be surpassed. In an era in which the practice of HSCT was restricted to few centers in high-income countries, we were taught that they could be done in low- and middle-income countries. Despite these outstanding achievements, in México, we are performing only 5-10% of all the HSCT that should ideally be done. We still have a long way to go along the road started by true giants.

REFERENCES

1. Thomas ED, Lochte HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 1957;257:491-6. [ Links ]

2. Sosa-Sánchez R, Córdova-Caballero MS, Labardini-Méndez J, Chávez-Peón F. Trasplante de médula ósea en anemia aplástica. Reporte del primer trasplante en México. Rev Invest Clin Mex. 1980;32:49-55. [ Links ]

Received: July 09, 2021; Accepted: July 10, 2021

* Corresponding author: Guillermo J. Ruiz-Argüelles E-mail: gruiz1@clinicaruiz.com

Creative Commons License Revista de Investigación Clínica. Published by Permanyer. This is an open ccess article under the CC BY-NC-ND license